Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 4/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.38 |
| ▸ | AIP | O00170 | 1/20 | 0.36 |
| ▸ | SGTA | O43765 | 1/20 | 0.36 |
| ▸ | TOMM70 | O94826 | 1/20 | 0.36 |
| ▸ | STIP1 | P31948 | 1/20 | 0.36 |
| ▸ | PPP5C | P53041 | 1/20 | 0.36 |
| ▸ | FKBP4 | Q02790 | 1/20 | 0.36 |
| ▸ | PPID | Q08752 | 1/20 | 0.36 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.36 |
| ▸ | FKBP8 | Q14318 | 1/20 | 0.36 |
| ▸ | TOMM34 | Q15785 | 1/20 | 0.36 |
| ▸ | DNAJC7 | Q99615 | 1/20 | 0.36 |
| ▸ | AIPL1 | Q9NZN9 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29030889 | 0.97 | POLB (0.52) | POLBALDH1A1KMT2AALOX15MEN1 | |
| SCHEMBL1003996 | 0.97 | POLB (0.52) | POLBALDH1A1KMT2AALOX15MEN1 | |
| SCHEMBL7406703 | 0.94 | POLB (0.50) | POLBALDH1A1KMT2AALOX15MEN1 | |
| SCHEMBL16781055 | 0.93 | POLB (0.55) | POLBALDH1A1KMT2AALOX15MEN1 | |
| SCHEMBL2221293 | 0.90 | POLB (0.52) | POLBALDH1A1KMT2AALOX15MEN1 | |
| SCHEMBL13948530 | 0.88 | POLB (0.46) | POLBALDH1A1KMT2AALOX15MEN1 | |
| SCHEMBL1003356 | 0.82 | POLB (0.41) | POLBALDH1A1KMT2AALOX15MEN1 | |
| SCHEMBL1004338 | 0.80 | POLB (0.47) | POLBALDH1A1KMT2AALOX15MEN1 | |
| SCHEMBL14349083 | 0.80 | POLB (0.44) | POLBALDH1A1KMT2AALOX15MEN1 | |
| SCHEMBL2221290 | 0.80 | POLB (0.44) | POLBALDH1A1KMT2AALOX15MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4013715-A | PROCESS FOR THE MANUFACTURE OF 2-HALO-ETHANE-PHOSPHONIC ACID DIHALIDES AND VINYL-PHOSPHONIC ACID DIHALIDES | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-03-22 | — | — | US | claimed |
| CN-119899359-A | Conductive high-molecular monomer composition, conductive polymer and electrolytic capacitor | 深圳新宙邦科技股份有限公司 | 2025-04-29 | — | — | CN | disclosed |
| CN-114761466-B | Curable resin composition, cured film, laminate, method for producing cured film, semiconductor device, and resin | 富士胶片株式会社 | 2024-12-10 | — | — | CN | disclosed |
| CN-111225940-B | Polymerization process | 杜邦聚合物公司 | 2023-10-10 | — | — | CN | disclosed |
| US-20110313197-A1 | METHOD FOR PRODUCING HALOGEN-SUBSTITUTED BENZENE DIMETHANOL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-12-22 | — | — | US | disclosed |
| WO-2011008664-A2 | IONIC LIQUIDS FOR SEPARATION OF OLEFIN-PARAFFIN MIXTURES | UT-BATTELLE, LLC (US) | 2011-01-20 | — | — | WO | disclosed |
| CN-101306613-B | Color imaging method | ZINK IMAGING LLC | 2010-11-24 | — | — | CN | disclosed |
| US-7498346-B2 | viricide, antiinflammatory agent; autoimmune diseases; protective effects against infection of target cells by a human immunodeficiency virus (HIV); 6-Chloro-N-((R)-3-{4-[(4-methoxy-phenyl)-(4-methyl-pyridin-3-ylmethyl)-amino]-piperidin-1-yl}-butyl)-2,4-dimethyl-nicotinamide | GENZYME CORPORATION (US) | 2009-03-03 | — | — | US | disclosed |
| CN-100448687-C | Imaging unit and imaging method | POLAROID CORP (US) | 2009-01-07 | — | — | CN | disclosed |
| CN-101306613-A | Color imaging method | ZINK IMAGING LLC (US) | 2008-11-19 | — | — | CN | disclosed |
| CN-1753793-A | Imaging system | POLAROID CORP (US) | 2006-03-29 | — | — | CN | disclosed |
| US-5210260-A | PROCESS FOR OBTAINING BIS(2,4-DI-TERT-BUTYLPHENYL) HALOPHOSPHITES | HOECHST AG (DE) | 1993-05-11 | — | — | US | disclosed |
| US-4990634-A | Novel tetracyanoanthraquinodimethane derivatives and process for producing same | FUJI XEROX CO., LTD. (JP) | 1991-02-05 | — | — | US | disclosed |
| US-3962324-A | Process for preparing halogenomethane-phosphonic acid dihalides | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110313197-A1 | METHOD FOR PRODUCING HALOGEN-SUBSTITUTED BENZENE DIMETHANOL | DBH, DDT, CBR3 | POLB 1977/4885ALDH1A1 906/4885KMT2A 206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.